What are Cresco Labs'stock price targets for the next year?
5 brokers have issued 12-month price targets for Cresco Labs' shares. Their forecasts range from $19.00 to $36.00. On average, they anticipate Cresco Labs' share price to reach $26.80 in the next year. This suggests a possible upside of 296.4% from the stock's current price.
When is Cresco Labs going to release its next quarterly earnings?
Cresco Labs is scheduled to release its next quarterly earnings announcement on Wednesday, March 23rd 2022. View our earnings forecast for Cresco Labs. What price target have analysts set for CRLBF?
Who is Cresco Labs?
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States.
Is Cresco Labs (CRL) short interest declining?
Cresco Labs saw a drop in short interest during the month of December. As of December 31st, there was short interest totaling 205,400 shares, a drop of 27.5% from the December 15th total of 283,300 shares. Based on an average daily trading volume, of 1,810,800 shares, the days-to-cover ratio is presently 0.1 days.
See more
Is Cresco Labs a Buy Sell or Hold?
Cresco Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.
How high will Cresco Labs stock go?
Stock Price Forecast The 17 analysts offering 12-month price forecasts for Cresco Labs Inc have a median target of 11.95, with a high estimate of 24.19 and a low estimate of 3.90. The median estimate represents a +295.80% increase from the last price of 3.02.
Does Cresco Labs pay a dividend?
Does Cresco issue dividends? No. The Company does not expect to issue dividends.
Is Cresco Labs a US stock?
CRLBF Stock Price | Cresco Labs Inc. Stock Quote (U.S.: OTC) | MarketWatch.
Should I invest in Cresco?
Valuation metrics show that Cresco Labs Inc. may be undervalued. Its Value Score of B indicates it would be a good pick for value investors. The financial health and growth prospects of CRLBF, demonstrate its potential to outperform the market.
Should I sell my Cresco Labs stock?
Cresco Labs Inc. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.
Is Cresco labs public?
Cresco Labs, Inc. is a publicly traded, vertically integrated cannabis and medical marijuana company based in Chicago, Illinois, with current retail operations in nine states where marijuana has been legalized for medical use.
Does Aurora stock pay a dividend?
ACB does not currently pay a dividend.
Is Cresco Labs good quality?
Cresco Labs brands are an excellent source for cannabis products that are high in THC and are of good quality. They offer various products, and customers can trust they get THC without heavy metals or hazardous chemicals. Additionally, this company has the potential to be a wise investment.
How many outstanding shares does Cresco Labs have?
Share StatisticsAvg Vol (3 month) 3571.31kShares Outstanding 5272.63MImplied Shares Outstanding 6N/AFloat 8222.84M% Held by Insiders 10.19%7 more rows
Is Cresco Labs OTC stock?
CRLBF | Cresco Labs Inc. Stock Overview (U.S.: OTC) | Barron's.
Should I buy or sell Cresco Labs stock right now?
7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last twelve months. There are current...
What is Cresco Labs' stock price forecast for 2022?
7 brokers have issued 1-year price objectives for Cresco Labs' stock. Their forecasts range from $5.00 to $36.00. On average, they predict Cresco L...
How has Cresco Labs' stock performed in 2022?
Cresco Labs' stock was trading at $6.67 on January 1st, 2022. Since then, CRLBF stock has decreased by 48.3% and is now trading at $3.45. View the...
Are investors shorting Cresco Labs?
Cresco Labs saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 867,900 shares, a drop of 35.0% fro...
When is Cresco Labs' next earnings date?
Cresco Labs is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022. View our earnings forecast for Cresco...
Who are Cresco Labs' key executives?
Cresco Labs' management team includes the following people: Mr. Charles Bachtell , Co-Founder, CEO & Director (Age 42, Pay $537.5k) Mr. Dennis M...
Who are some of Cresco Labs' key competitors?
Some companies that are related to Cresco Labs include Tilray (TLRY) , Canopy Growth (CGC) , USANA Health Sciences (USNA) , Cronos Group (CRON)...
What is Cresco Labs' stock symbol?
Cresco Labs trades on the OTCMKTS under the ticker symbol "CRLBF."
How do I buy shares of Cresco Labs?
Shares of CRLBF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBu...
About Cresco Labs
Cresco Labs (OTCMKTS:CRLBF) Frequently Asked Questions
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States.
Stocks rise into market close
4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Cresco Labs stock. View analyst ratings for Cresco Labs or view top-rated stocks.
GOP Congresswoman Nancy Mace talks 5G and airplanes, autonomous vehicles, weed decriminalization
Yahoo Finance's Jared Bilkre gives a recap of the market before it closes for the day.
Acquisitions are a budding opportunity
Congresswoman Nancy Mace (R-SC) joins Yahoo Finance Live to discuss 5G and airlines, regulation for autonomous vehicles, and the proposed States Reform Act to reform federal cannabis laws.
Multipronged growth strategy
Cresco Labs certainly has a lot working for it in its favor. In November, it closed on its acquisition of Cure Pennsylvania, which added three dispensaries to its portfolio.
Rocket in flight?
What helps set Cresco apart from many of its rivals is its leading wholesale business. Although wholesale cannabis is lower margin than retail sales, it can make up for that with volume.
The Motley Fool
Investors would do well to consider the business and not the stock price since if a company is successful, its share price will likely follow over time.
Key Points
Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community.
OTC: CRLBF
The study examined more than 33,000 young adults and found that heart attacks were more frequent among cannabis users.
What happened
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
So what
Shares of the medical marijuana company Cresco Labs ( CRLBF -4.46% ) had fallen roughly 12% this week, as of 2:35 p.m. EDT, for no obvious reason other than negative sentiment in the broader sector.
Now what
The main reason marijuana stocks seem to be struggling has to do with a recent report from the Canadian Medical Association Journal that found a link between the use of marijuana and heart attacks.
Premium Investing Services
Cresco recently completed the acquisition of Cultivate, a Massachusetts cannabis cultivator, and not too long ago reported earnings results for the second quarter that handily beat estimates from analysts.
